Afatinib Withdrawn Phase 2 Trials for Esophageal Cancers / Gastrooesophageal Cancer / Her-2 Positive Gastric Cancer Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02274012Trial of Afatinib in Combination With Weekly Paclitaxel in the Second Line Treatment